ACTL6A and head and neck squamous cell carcinoma: This observation parallels the genomic amplification described for ACTL6A in head and neck squamous cell carcinoma (HNSCC) [48] and confirms a possible function of ACTL6A as an oncogenic driver in squamous cell carcinomas of different origins.